91 Results for "

Antituberculosis activity

" in MedChemExpress (MCE) Product Catalog:
Products (91)

91 Results for "Antituberculosis activity" in MCE Product Catalog:

Cat. No.: HY-117126
CAS No.: 1839081-05-8
Target:  

Bacterial

Research Areas:  

Infection

BTZ-N3 is a potent reversible and noncovalent inhibitor of decaprenylphosphoryl-β-d-ribose 2′ oxidase (DprE1) that shows anti-tuberculosis activity .
loading...
    loading...
Cat. No.: HY-122448A
CAS No.: 71831-00-0
(Rac)-Sativan is an isoflavanoid with a broad spectrum of antimicrobial activity against bacteria and phytopathogenic fungi. (Rac)-Sativan exhibits antituberculosis activity against Mycobacterium tuberculosis H37Rv, with MIC values of 50 µg/mL .
loading...
    loading...
Cat. No.: HY-155067
CAS No.: 3049713-85-8
Target:  

Bacterial

Research Areas:  

Infection

Antitubercular agent-38 is an orally active Benzothiazinones (BTZs) derivate, with potent antituberculosis activity. Antitubercular agent-38 exhibits low cardiac toxicity, low cell cytotoxicity .
loading...
    loading...
Cat. No.: HY-162028
CAS No.: 2568607-82-7
Target:  

Bacterial

Research Areas:  

Infection

GaMF1.39 is an antimycobacterial compound, targeting the F-ATP synthase subunit γ. GaMF1.39 displays enhanced anti-tuberculosis activity in combination with ETC inhibitors .
loading...
    loading...
Cat. No.: HY-119166
CAS No.: 87-10-5
Target:  

Bacterial

Research Areas:  

Others

3,5,4'-Tribromosalicylanilide is a compound with antituberculosis and anti-Mycobacterium abscessus activities, which was found to inhibit the growth of Mycobacterium tuberculosis and Mycobacterium abscessus and affect gene expression by computational compound repositioning approach.
loading...
    loading...
Cat. No.: HY-168946
Target:  

Bacterial

Research Areas:  

Infection

InhA-IN-9 (compound 7h) is a Mycobacterium tuberculosis InhA (an enoyl ACP-reductase) inhibitor. InhA-IN-9 could bind to InhA. InhA-IN-9 shows a antituberculosis activity at MIC value of 2 μg/mL .
loading...
    loading...
Cat. No.: HY-169108
Target:  

Bacterial

Research Areas:  

Infection

DprE1-IN-11 (compound 3) is an orally active DprE1 inhibitor with antituberculosis activity against MTB H37Rv and MDR-MTB strains (MIC <0.029-0.095 μM) .
loading...
    loading...
Cat. No.: HY-W013677S
4-Fluorobenzoic acid- 13C6 is the 13C6 labeled 4-Fluorobenzoic acid (HY-W013677). 4-Fluorobenzoic acid is a drug intermediate that can be used to synthesize a series of hydrazone derivatives with antituberculosis activity and Schiff bases with DPPH radical scavenging activity.
loading...
    loading...
Cat. No.: HY-N13197
CAS No.: 108-54-3
6-Methyl-5,6-dihydro-2H-pyran-2-one is a heterocyclic compound with antitumor, antifungal, antimicrobial, anti-inflammatory, antistress, antibiotic, antituberculosis, antiparasitic, antiviral activities .
loading...
    loading...
Cat. No.: HY-116943
CAS No.: 2088930-66-7
Target:  

Bacterial

Research Areas:  

Infection

MTC420 (compound 42a) is a heterocyclic quinolone compound that targets the respiratory chain of Mycobacterium tuberculosis and exhibits antituberculosis activity (Rep Mtb: IC50=525 nM, Wayne Mtb: IC50=76 nM, MDR Mtb: IC50=140 nM) .
loading...
    loading...
Cat. No.: HY-114604
CAS No.: 102962-95-8
Target:  

Bacterial

Propioxatin B is a tricyclic sesquiterpenoid compound isolated from the root of vetiver grass. It has anti-tuberculosis activity and inhibitory effects on a variety of drug-resistant mutants of Mycobacterium tuberculosis. In computer simulation docking studies, it showed binding affinity with bacterial DNA gyrase and has a certain safety in vivo.
loading...
    loading...
Cat. No.: HY-W026339
CAS No.: 921812-26-2
Target:  

Bacterial

Research Areas:  

Infection

IMB-XMA0038 is a MtASADH inhibitor with an IC50 value of 0.59 μg/mL. IMB-XMA0038 inhibits various agent-resistant Mycobacteria tuberculosis potently with MICs of 0.25-0.5 μg/mL. IMB-XMA0038 shows anti-tuberculosis activity .
loading...
    loading...
Cat. No.: HY-162527
Target:  

Bacterial

Research Areas:  

Infection

Antibacterial agent 216 (Compound 2a) is an antibacterial agent that exhibits significant bactericidal effects when combined with INH and RIF. Antibacterial agent 216 has demonstrated remarkable in vitro anti-tuberculosis activity against Mtb H37Rv and MDR clinical isolates and can be used for tuberculosis research .
loading...
    loading...
Cat. No.: HY-150967
CAS No.: 2290534-93-7
Target:  

Bacterial

Research Areas:  

Infection

MmpL3-IN-1 (compound 32) is a potent Mycobacterial membrane protein large 3 (MmpL3) inhibitor. MmpL3-IN-1 has anti-tuberculosis activity with the MIC<0.016 μg/mL in M. tuberculosis and can be used in studies of drug-resistant tuberculosis .
loading...
    loading...
Cat. No.: HY-172462
Target:  

Bacterial

Research Areas:  

Infection

Mtb-IN-11 (Compound 1e) is an inhibitor of Mycobacterium tuberculosis salicylate synthase (MbtI), with an IC50 of 11.2 μM. Mtb-IN-11 exhibits good in vitro anti-tuberculosis activity, with a MIC99 of 32 μM against M. bovis BCG. Mtb-IN-11 can be used for the research of tuberculosis .
loading...
    loading...
Cat. No.: HY-134940S
Synonyms: OPC-167832-d7
Quabodepistat-d7 (OPC-167832-d7) is deuterium labeled Quabodepistat. Quabodepistat (OPC-167832) is a potent and orally active dprE1 inhibitor with?an IC50 of 0.258 μM. Quabodepistat has antituberculosis activity and can be used for the research of tuberculosis?caused by?Mycobacterium tuberculosis .
loading...
    loading...
Cat. No.: HY-173355
CAS No.: 3052630-27-7
Target:  

Bacterial

Research Areas:  

Infection

RCB18350 is an antituberculosis agent that belongs to the class of isoxazole derivatives. RCB18350 has bacteriostatic activity and inhibits the growth of Mycobacterium tuberculosis with an MIC of 1.25 μg/mL. RCB18350 is effective against multidrug-resistant Mycobacterium tuberculosis (MDR-TB) clinical isolates, slow-growing mycobacteria such as Mycobacterium bovis BCG and Mycobacterium avium .
loading...
    loading...
Cat. No.: HY-177322
CAS No.: 1357746-77-0
Target:  

Bacterial

Research Areas:  

Infection

sCNH240 (Compound P1) is an oral active and selective Rv1625c/Cya activator. sCNH240 has significant anti-tuberculosis activity with a MIC90 of 1.24 μM for Mycobacterium tuberculosis (Mtb) H37Rv strain on cholesterol. sCNH240 can be used for tuberculosis research .
loading...
    loading...
Cat. No.: HY-137604A
Research Areas:  

Infection

(γ-AmNS)UTP (trisodium) is a fluorescent derivative of UTP and enables the detection of RNA polymerase activity. Incorporation of UMP in RNA results in the release of γ-AmNS-PPi, which has higher intrinsic fluorescence than (γ-AmNS) UTP. (γ-AmNS)UTP (trisodium) can be used for antibacterial and antituberculosis agents study .
loading...
    loading...
Cat. No.: HY-159565
Target:  

Bacterial VEGFR

Research Areas:  

Infection

VEGFR-2/InhA-IN-1 is a pyrazole-based dual inhibitor of InhA-VEGFR with anti-tuberculosis and anti-angiogenic activities. VEGFR-2/InhA-IN-1 has good antibacterial activity against Mycobacterium tuberculosis H37Rv strain (MIC=6.25 μg/mL) and significantly inhibits VEGFR-2 (IC50=15.27 nM) .
loading...
    loading...